Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada

Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada

Abstract Background Amidst a sustained drug poisoning crisis, there is growing recognition in Canada of the need to expand injectable opioid agonist treatment (iOAT). iOAT is an intensive treatment that involves the daily self-administration of hydromorphone or diacetylmorphine under healthcare prov...

Full description

Saved in:
Bibliographic Details
Main Authors: Samara Mayer, Nadia Fairbairn, Al Fowler, Jade Boyd, Thomas Kerr, Ryan McNeil
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Harm Reduction Journal
Subjects:
Injectable opioid agonist treatment
Qualitative
Ethnography
Structural vulnerability
Patient engagement
Online Access:https://doi.org/10.1186/s12954-025-01262-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12954-025-01262-4

Similar Items